Skip to Content

Cipla 517 50 MG (Cyclophosphamide 50 mg)

Pill with imprint Cipla 517 50 MG is Blue & White, Capsule-shape and has been identified as Cyclophosphamide 50 mg. It is supplied by Cipla USA Inc..

Cyclophosphamide is used in the treatment of acute lymphocytic leukemia; breast cancer; acute nonlymphocytic leukemia; cancer; chronic lymphocytic leukemia and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Cyclophosphamide 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Cipla 517 50 MG

Cyclophosphamide 50 mg Cipla 517 50 MG

Cyclophosphamide

Imprint
Cipla 517 50 MG
Strength
50 mg
Color
Blue & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0517

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.